These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24167183)

  • 1. Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours.
    Batth SS; Sreeraman R; Dienes E; Beckett LA; Daly ME; Cui J; Mathai M; Purdy JA; Chen AM
    Br J Radiol; 2013 Dec; 86(1032):20130459. PubMed ID: 24167183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
    Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
    Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-dosimetric relationship between lacrimal gland dose and keratoconjunctivitis sicca in dogs with sinonasal tumors treated with radiation therapy.
    Poirier VJ; Matsuyama A; Kim C; Darko J; Fleck A
    J Vet Intern Med; 2020 Mar; 34(2):867-872. PubMed ID: 32086981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Dirix P; Vanstraelen B; Jorissen M; Vander Poorten V; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):998-1004. PubMed ID: 20338694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
    Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
    Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome?
    Claus F; Boterberg T; Ost P; De Neve W
    Radiother Oncol; 2002 Aug; 64(2):205-8. PubMed ID: 12242131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses.
    Daly ME; Chen AM; Bucci MK; El-Sayed I; Xia P; Kaplan MJ; Eisele DW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):151-7. PubMed ID: 17189068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective pilot study on early toxicity from a simultaneously integrated boost technique for canine sinonasal tumours using image-guided intensity-modulated radiation therapy.
    Soukup A; Meier V; Pot S; Voelter K; Rohrer Bley C
    Vet Comp Oncol; 2018 Dec; 16(4):441-449. PubMed ID: 29761663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.
    Duprez F; Madani I; Morbée L; Bonte K; Deron P; Domján V; Boterberg T; De Gersem W; De Neve W
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):252-9. PubMed ID: 22027259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma.
    Wang H; Li YX; Wang WH; Jin J; Dai JR; Wang SL; Liu YP; Song YW; Wang ZY; Liu QF; Fang H; Qi SN; Liu XF; Yu ZH
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1115-21. PubMed ID: 21514070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
    Kim SE; Yang HJ; Yang SW
    BMC Ophthalmol; 2020 Jan; 20(1):24. PubMed ID: 31931766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective dosimetric and clinical comparison of acute hematological toxicities in three-dimensional conformal radiation therapy and intensity modulated radiation therapy with concurrent chemotherapy in carcinoma cervix.
    Avinash HU; Arul Ponni TR; Janaki MG; Kirthi Koushik AS; Kumar SM
    J Cancer Res Ther; 2015; 11(1):83-7. PubMed ID: 25879342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of skin toxicity in patients with extranodal nasal-type natural killer/T-cell lymphoma after treatment with intensity-modulated radiotherapy and conventional radiotherapy.
    Gu Y; Yu H; Zuo X; Cao Q; Liang T; Ren Y; Yang H; Yang D
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S975-S979. PubMed ID: 30539832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
    Wan J; Liu K; Li K; Li G; Zhang Z
    Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.
    Dirix P; Nuyts S; Vanstraelen B; Nulens A; Hermans R; Jorissen M; Vander Poorten V; Van den Bogaert W
    Radiother Oncol; 2007 Dec; 85(3):385-91. PubMed ID: 17963908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.